{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T23:44:39Z","timestamp":1781826279395,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzen Municipality","doi-asserted-by":"publisher","award":["SZSM202011005"],"award-info":[{"award-number":["SZSM202011005"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Health Project and the Guangdong High-level Hospital Construction Fund","award":["ynkt2021-zz47"],"award-info":[{"award-number":["ynkt2021-zz47"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-01567-7","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T13:31:38Z","timestamp":1738243898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessment of cardiac iron deposition and genotypic classification in pediatric beta-thalassemia major: the role of cardiac MRI"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1382-0708","authenticated-orcid":false,"given":"Siqi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0059-5427","authenticated-orcid":false,"given":"Wen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longwei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohua","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7832-3702","authenticated-orcid":false,"given":"Hongwu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"key":"1567_CR1","doi-asserted-by":"publisher","unstructured":"Kattamis A, Kwiatkowski JL, Aydinok Y. Thalassaemia. Lancet. 2022;399(10343):2310\u201324. https:\/\/doi.org\/10.1016\/S0140-6736(22)00536-0","DOI":"10.1016\/S0140-6736(22)00536-0"},{"issue":"11","key":"1567_CR2","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s40265-020-01341-9","volume":"80","author":"I Motta","year":"2020","unstructured":"Motta I, Bou-Fakhredin R, Taher AT, Cappellini MD. Beta thalassemia: new therapeutic options beyond transfusion and iron chelation. Drugs. 2020;80(11):1053\u201363. https:\/\/doi.org\/10.1007\/s40265-020-01341-9","journal-title":"Drugs"},{"issue":"3","key":"1567_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/ehjci\/jex012","volume":"19","author":"A Pepe","year":"2018","unstructured":"Pepe A, Meloni A, Rossi G, Midiri M, Missere M, Valeri G, Sorrentino F, D\u2019Ascola DG, Spasiano A, Filosa A, et al. Prediction of cardiac complications for Thalassemia major in the widespread cardiac magnetic resonance era: a prospective multicentre study by a multi-parametric approach. Eur Heart J Cardiovasc Imaging. 2018;19(3):299\u2013309. https:\/\/doi.org\/10.1093\/ehjci\/jex012","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1567_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-024-05715-x","author":"KM Musallam","year":"2024","unstructured":"Musallam KM, Barella S, Origa R, Ferrero GB, Lisi R, Pasanisi A, Longo F, Gianesin B, Forni GL. Webthal p: revisiting iron overload status and change thresholds as predictors of mortality in transfusion-dependent beta-thalassemia: a 10-year cohort study. Ann Hematol. 2024. https:\/\/doi.org\/10.1007\/s00277-024-05715-x","journal-title":"Ann Hematol"},{"issue":"3","key":"1567_CR5","first-page":"692","volume":"4","author":"M Saravi","year":"2013","unstructured":"Saravi M, Tamadoni A, Jalalian R, Mahmoodi\u2013Nesheli H, Hojati M, Ramezani S. Evaluation of tissue doppler echocardiography and T2* magnetic resonance imaging in iron load of patients with Thalassemia major. Caspian J Intern Med. 2013;4(3):692.","journal-title":"Caspian J Intern Med"},{"issue":"20","key":"1567_CR6","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1161\/CIRCULATIONAHA.109.874487","volume":"120","author":"P Kirk","year":"2009","unstructured":"Kirk P, Roughton M, Porter JB, Walker JM, Tanner MA, Patel J, Wu D, Taylor J, Westwood MA, Anderson LJ. Cardiac T2* magnetic resonance for prediction of cardiac complications in Thalassemia major. Circulation. 2009;120(20):1961\u20138.","journal-title":"Circulation"},{"issue":"1","key":"1567_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1532-429X-10-42","volume":"10","author":"B Modell","year":"2008","unstructured":"Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ. Improved survival of Thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2008;10(1):42. https:\/\/doi.org\/10.1186\/1532-429X-10-42","journal-title":"J Cardiovasc Magn Reson"},{"issue":"8","key":"1567_CR8","doi-asserted-by":"publisher","first-page":"e732","DOI":"10.1097\/HS9.0000000000000732","volume":"6","author":"D Farmakis","year":"2022","unstructured":"Farmakis D, Porter J, Taher A, Domenica Cappellini M, Angastiniotis M, Eleftheriou A. 2021 Thalassaemia International Federation guidelines for the management of transfusion-dependent thalassemia. Hemasphere. 2022;6(8):e732. https:\/\/doi.org\/10.1097\/HS9.0000000000000732","journal-title":"Hemasphere"},{"issue":"12","key":"1567_CR9","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1007\/s00330-011-2208-1","volume":"21","author":"JL Fernandes","year":"2011","unstructured":"Fernandes JL, Sampaio EF, Verissimo M, Pereira FB, da Silva JA, de Figueiredo GS, Kalaf JM, Coelho OR. Heart and liver T2 assessment for iron overload using different software programs. Eur Radiol. 2011;21(12):2503\u201310. https:\/\/doi.org\/10.1007\/s00330-011-2208-1","journal-title":"Eur Radiol"},{"issue":"1053","key":"1567_CR10","doi-asserted-by":"publisher","first-page":"20150269","DOI":"10.1259\/bjr.20150269","volume":"88","author":"KA Git","year":"2015","unstructured":"Git KA, Fioravante LA, Fernandes JL. An online open-source tool for automated quantification of liver and myocardial iron concentrations by T2* magnetic resonance imaging. Br J Radiol. 2015;88(1053):20150269. https:\/\/doi.org\/10.1259\/bjr.20150269","journal-title":"Br J Radiol"},{"issue":"6","key":"1567_CR11","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3109\/03014460.2014.990921","volume":"42","author":"CS Sagar","year":"2015","unstructured":"Sagar CS, Kumar R, Sharma DC, Kishor P. DNA damage: beta zero versus beta plus thalassemia. Ann Hum Biol. 2015;42(6):585\u20138. https:\/\/doi.org\/10.3109\/03014460.2014.990921","journal-title":"Ann Hum Biol"},{"key":"1567_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/978-3-030-78787-5_10","volume":"1339","author":"AT Lambrou","year":"2021","unstructured":"Lambrou AT, Samartzi GI, Vlachou A, Papassotiriou E, Geronikolou I, Kanaka-Gantenbein SA, Chrousos C, Kattamis GP. Genotypic and clinical analysis of a Thalassemia major cohort: an observational study. Adv Exp Med Biol. 2021;1339:65\u201376. https:\/\/doi.org\/10.1007\/978-3-030-78787-5_10","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"1567_CR13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.2450\/2020.0023-20","volume":"19","author":"L Pistoia","year":"2021","unstructured":"Pistoia L, Meloni A, Ricchi P, Filosa A, Lisi R, Maggio A, Rosso R, Messina G, Iacono ND, Cuccia L, et al. Genotypic groups as risk factors for cardiac magnetic resonance abnormalities and complications in Thalassemia major: a large, multicentre study. Blood Transfus. 2021;19(2):168\u201376. https:\/\/doi.org\/10.2450\/2020.0023-20","journal-title":"Blood Transfus"},{"key":"1567_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcmd.2019.01.008","volume":"77","author":"L Pistoia","year":"2019","unstructured":"Pistoia L, Meloni A, Salvadori S, Spasiano A, Lisi R, Rosso R, Maggio A, D\u2019Ascola DG, Cuccia L, Mangione M, et al. Cardiac involvement by CMR in different genotypic groups of Thalassemia major patients. Blood Cells Mol Dis. 2019;77:1\u20137. https:\/\/doi.org\/10.1016\/j.bcmd.2019.01.008","journal-title":"Blood Cells Mol Dis"},{"issue":"3","key":"1567_CR15","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.ijcard.2014.09.139","volume":"177","author":"A Meloni","year":"2014","unstructured":"Meloni A, Restaino G, Borsellino Z, Caruso V, Spasiano A, Zuccarelli A, Valeri G, Toia P, Salvatori C, Positano V, et al. Different patterns of myocardial iron distribution by whole-heart T2* magnetic resonance as risk markers for heart complications in Thalassemia major. Int J Cardiol. 2014;177(3):1012\u20139. https:\/\/doi.org\/10.1016\/j.ijcard.2014.09.139","journal-title":"Int J Cardiol"},{"issue":"23","key":"1567_CR16","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1053\/euhj.2001.2822","volume":"22","author":"LJ Anderson","year":"2001","unstructured":"Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, Firmin DN, Wonke B, Porter J, Walker JM, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22(23):2171\u20139. https:\/\/doi.org\/10.1053\/euhj.2001.2822","journal-title":"Eur Heart J"},{"issue":"20","key":"1567_CR17","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1161\/CIRCULATIONAHA.109.874487","volume":"120","author":"P Kirk","year":"2009","unstructured":"Kirk P, Roughton M, Porter JB, Walker JM, Tanner MA, Patel J, Wu D, Taylor J, Westwood MA, Anderson LJ, et al. Cardiac T2* magnetic resonance for prediction of cardiac complications in Thalassemia major. Circulation. 2009;120(20):1961\u20138. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.874487","journal-title":"Circulation"},{"issue":"2","key":"1567_CR18","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00431-023-05300-w","volume":"183","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Cao Y, Fang Z, Huang K, Yang M, Pang G, Zhao J, Liu Y, Luo J. Research on the clinical factors of cardiac iron deposition in children with beta-thalassemia major. Eur J Pediatr. 2024;183(2):875\u201382. https:\/\/doi.org\/10.1007\/s00431-023-05300-w","journal-title":"Eur J Pediatr"},{"key":"1567_CR19","doi-asserted-by":"publisher","unstructured":"El Sherif AM, Ibrahim AS, Elsayed MA, Abdelhakim AS, Ismail AM. The impact of magnetic resonance imaging in the assessment of iron overload in heart and liver in transfusion-dependent thalassemic children: Minia experience. Egypt J Radiol Nuclear Med. 2021;52(1). https:\/\/doi.org\/10.1186\/s43055-021-00645-4","DOI":"10.1186\/s43055-021-00645-4"},{"issue":"1","key":"1567_CR20","doi-asserted-by":"publisher","first-page":"19652","DOI":"10.1038\/s41598-023-46524-y","volume":"13","author":"F Xu","year":"2023","unstructured":"Xu F, Li D, Tang C, Liang B, Guan K, Liu R, Peng P. Magnetic resonance imaging assessment of the changes of cardiac and hepatic iron load in Thalassemia patients before and after hematopoietic stem cell transplantation. Sci Rep. 2023;13(1):19652. https:\/\/doi.org\/10.1038\/s41598-023-46524-y","journal-title":"Sci Rep"},{"issue":"1","key":"1567_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00277-016-2841-5","volume":"96","author":"M Ouederni","year":"2017","unstructured":"Ouederni M, Ben Khaled M, Mellouli F, Ben Fraj E, Dhouib N, Yakoub IB, Abbes S, Mnif N, Bejaoui M. Myocardial and liver iron overload, assessed using T2* magnetic resonance imaging with an Excel spreadsheet for post processing in Tunisian Thalassemia major patients. Ann Hematol. 2017;96(1):133\u20139. https:\/\/doi.org\/10.1007\/s00277-016-2841-5","journal-title":"Ann Hematol"},{"key":"1567_CR22","doi-asserted-by":"publisher","unstructured":"Ansah D, Husain N, Ruh A, Berhane H, Smith A, Thompson A, De Freitas A, Rigsby CK, Robinson JD. Cardiac magnetic resonance strain in beta Thalassemia major correlates with cardiac iron overload. Child (Basel). 2023;10(2). https:\/\/doi.org\/10.3390\/children10020271","DOI":"10.3390\/children10020271"},{"issue":"5","key":"1567_CR23","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/bjh.14712","volume":"178","author":"R Di Maggio","year":"2017","unstructured":"Di Maggio R, Maggio A. The new era of chelation treatments: effectiveness and safety of 10 different regimens for controlling iron overloading in Thalassaemia major. Br J Haematol. 2017;178(5):676\u201388. https:\/\/doi.org\/10.1111\/bjh.14712","journal-title":"Br J Haematol"},{"key":"1567_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-024-05694-z","author":"EJ Bardon-Cancho","year":"2024","unstructured":"Bardon-Cancho EJ, Marco-Sanchez JM, Beneitez-Pastor D, Payan-Pernia S, Llobet AR, Berrueco R, Garcia-Morin M, Belendez C, Senent L, Acosta MJO, et al. Spanish registry of hemoglobinopathies and rare anemias (REHem-AR): demographics, complications, and management of patients with beta-thalassemia. Ann Hematol. 2024. https:\/\/doi.org\/10.1007\/s00277-024-05694-z","journal-title":"Ann Hematol"},{"issue":"1","key":"1567_CR25","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1080\/07853890.2022.2028894","volume":"54","author":"PS Reddy","year":"2022","unstructured":"Reddy PS, Locke M, Badawy SM. A systematic review of adherence to iron chelation therapy among children and adolescents with thalassemia. Ann Med. 2022;54(1):326\u201342. https:\/\/doi.org\/10.1080\/07853890.2022.2028894","journal-title":"Ann Med"},{"issue":"1","key":"1567_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3324\/haematol.2009.019042","volume":"96","author":"A Pepe","year":"2011","unstructured":"Pepe A, Meloni A, Capra M, Cianciulli P, Prossomariti L, Malaventura C, Putti MC, Lippi A, Romeo MA, Bisconte MG, et al. Deferasirox, deferiprone and desferrioxamine treatment in Thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging. Haematologica. 2011;96(1):41\u20137. https:\/\/doi.org\/10.3324\/haematol.2009.019042","journal-title":"Haematologica"},{"issue":"1","key":"1567_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2450\/BloodTransfus.485","volume":"22","author":"P Ricchi","year":"2024","unstructured":"Ricchi P, Meloni A, Pistoia L, Gamberini MR, Cuccia L, Allo M, Putti MC, Spasiano A, Rosso R, Cecinati V, et al. Longitudinal prospective comparison of pancreatic iron by magnetic resonance in Thalassemia patients transfusion-dependent since early childhood treated with combination deferiprone-desferrioxamine vs deferiprone or deferasirox monotherapy. Blood Transfus. 2024;22(1):75\u201385. https:\/\/doi.org\/10.2450\/BloodTransfus.485","journal-title":"Blood Transfus"},{"issue":"14","key":"1567_CR28","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.110.007641","volume":"123","author":"JP Carpenter","year":"2011","unstructured":"Carpenter JP, He T, Kirk P, Roughton M, Anderson LJ, de Noronha SV, Sheppard MN, Porter JB, Walker JM, Wood JC, et al. On T2* magnetic resonance and cardiac iron. Circulation. 2011;123(14):1519\u201328. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.007641","journal-title":"Circulation"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01567-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-01567-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01567-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T13:31:41Z","timestamp":1738243901000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-025-01567-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1567"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-01567-7","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"assertion":[{"value":"9 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval: The studies involving human participants were reviewed and approved by the Medical Ethics Committee of the local hospital (No. 202004002).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All the participants and guardians of adolescents signed a written informed consent form after receiving a complete study description.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The work described has not been published previously and is not under consideration for publication elsewhere.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Submission declaration and verification"}},{"value":"While preparing this work, the authors didn\u2019t use any tools for article writing.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Artificial intelligence"}}],"article-number":"31"}}